on NOVACYT (EPA:ALNOV)
Novacyt: Update on liquidity contract and voting rights
Novacyt, a leading molecular diagnostics company, has published its monthly report on its liquidity agreement with Invest Securities. During April 2025, 20,519 shares were purchased at prices ranging from €0.42 to €0.50, while 15,517 shares were sold. At the end of the month, Novacyt held 92,902 treasury shares.
The total number of ordinary shares remains at 70,626,248, allowing shareholders to calculate their interest in the company. Novacyt, listed on Euronext Growth and AIM, is not subject to the Financial Conduct Authority's transparency rules.
The liquidity agreement, initiated in September 2016, allows Invest Securities to purchase shares on behalf of Novacyt, with a ceiling set at €5.00 per share.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all NOVACYT news